PRTK Annual Revenue
$150.79 M
+$29.84 M+24.67%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual revenue is $150.79 million, with the most recent change of +$29.84 million (+24.67%) on December 31, 2022. During the last 3 years, it has risen by +$134.24 million (+811.44%).PRTK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Revenue
$38.06 M
+$8.85 M+30.31%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly revenue is $38.06 million, with the most recent change of +$8.85 million (+30.31%) on June 30, 2023. Over the past year, it has increased by +$10.51 million (+38.13%).PRTK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM Revenue
$167.74 M
+$10.51 M+6.68%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM revenue is $167.74 million, with the most recent change of +$10.51 million (+6.68%) on June 30, 2023. Over the past year, it has increased by +$66.69 million (+66.00%).PRTK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.7% | +38.1% | +66.0% |
| 3 y3 years | +811.4% | +328.2% | +464.6% |
| 5 y5 years | +1095.2% | +10000.0% | +913.9% |
PRTK Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -47.6% | at high |
Paratek Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $38.06 M(+30.3%) | $167.74 M(+6.7%) |
| Mar 2023 | - | $29.21 M(-59.8%) | $157.24 M(+4.3%) |
| Dec 2022 | $150.79 M(+24.7%) | $72.63 M(+160.8%) | $150.79 M(+40.3%) |
| Sept 2022 | - | $27.84 M(+1.1%) | $107.46 M(+6.3%) |
| June 2022 | - | $27.55 M(+21.1%) | $101.05 M(-21.6%) |
| Mar 2022 | - | $22.76 M(-22.3%) | $128.90 M(+6.6%) |
| Dec 2021 | $120.95 M(+177.9%) | $29.30 M(+36.7%) | $120.95 M(+13.5%) |
| Sept 2021 | - | $21.44 M(-61.3%) | $106.57 M(+9.9%) |
| June 2021 | - | $55.41 M(+274.0%) | $96.93 M(+92.3%) |
| Mar 2021 | - | $14.81 M(-0.7%) | $50.41 M(+15.8%) |
| Dec 2020 | $43.52 M(+163.0%) | $14.92 M(+26.5%) | $43.52 M(+15.8%) |
| Sept 2020 | - | $11.79 M(+32.7%) | $37.57 M(+26.5%) |
| June 2020 | - | $8.89 M(+12.2%) | $29.71 M(+29.9%) |
| Mar 2020 | - | $7.92 M(-11.7%) | $22.87 M(+38.2%) |
| Dec 2019 | $16.54 M(-3.3%) | $8.97 M(+127.9%) | $16.54 M(-32.7%) |
| Sept 2019 | - | $3.93 M(+92.4%) | $24.59 M(+18.8%) |
| June 2019 | - | $2.04 M(+28.0%) | $20.71 M(+10.7%) |
| Mar 2019 | - | $1.60 M(-90.6%) | $18.70 M(+9.3%) |
| Dec 2018 | $17.12 M(+35.7%) | $17.02 M(>+9900.0%) | $17.12 M(+230.9%) |
| Sept 2018 | - | $50.00 K(+25.0%) | $5.17 M(+0.7%) |
| June 2018 | - | $40.00 K(+300.0%) | $5.13 M(-59.3%) |
| Mar 2018 | - | $10.00 K(-99.8%) | $12.61 M(-0.1%) |
| Dec 2017 | $12.62 M(>+9900.0%) | $5.07 M(>+9900.0%) | $12.62 M(+66.6%) |
| Sept 2017 | - | $12.00 K(-99.8%) | $7.57 M(+0.2%) |
| June 2017 | - | $7.51 M(>+9900.0%) | $7.56 M(>+9900.0%) |
| Mar 2017 | - | $18.00 K(-37.9%) | $47.00 K(+62.1%) |
| Dec 2016 | $29.00 K(-99.3%) | $29.00 K(-99.1%) | $29.00 K(-99.3%) |
| Dec 2014 | $4.34 M(+148.5%) | $3.38 M(+1757.1%) | $4.34 M(+239.7%) |
| Sept 2014 | - | $182.00 K(-49.7%) | $1.28 M(-18.3%) |
| June 2014 | - | $362.00 K(-13.4%) | $1.56 M(-7.1%) |
| Mar 2014 | - | $418.00 K(+32.3%) | $1.68 M(-3.7%) |
| Dec 2013 | $1.75 M | $316.00 K(-32.5%) | $1.75 M(+14.6%) |
| Sept 2013 | - | $468.00 K(-2.7%) | $1.52 M(-86.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | $481.00 K(-0.2%) | $11.50 M(-0.1%) |
| Mar 2013 | - | $482.00 K(+418.3%) | $11.51 M(+4.4%) |
| Dec 2012 | $11.03 M(-44.0%) | $93.00 K(-99.1%) | $11.03 M(-53.6%) |
| Sept 2012 | - | $10.44 M(+2017.6%) | $23.75 M(+70.4%) |
| June 2012 | - | $493.00 K(-96.2%) | $13.94 M(-29.2%) |
| Dec 2011 | $19.69 M(+57.6%) | $12.82 M(+1951.0%) | $19.69 M(+96.9%) |
| Sept 2011 | - | $625.00 K(-80.0%) | $10.00 M(-20.0%) |
| June 2011 | - | $3.13 M(0.0%) | $12.50 M(0.0%) |
| Mar 2011 | - | $3.13 M(0.0%) | $12.50 M(0.0%) |
| Dec 2010 | $12.50 M(+140.0%) | $3.13 M(0.0%) | $12.50 M(0.0%) |
| Sept 2010 | - | $3.13 M(0.0%) | $12.50 M(+9.1%) |
| June 2010 | - | $3.13 M(0.0%) | $11.46 M(+37.5%) |
| Mar 2010 | - | $3.13 M(0.0%) | $8.33 M(+60.0%) |
| Dec 2009 | $5.21 M(-68.8%) | $3.13 M(+50.0%) | $5.21 M(-108.9%) |
| Sept 2009 | - | $2.08 M(-103.4%) | -$58.54 M(<-9900.0%) |
| Dec 2008 | - | -$60.62 M(<-9900.0%) | $0.00(-100.0%) |
| Sept 2008 | - | $93.00 K(-99.8%) | $68.60 M(-11.0%) |
| June 2008 | - | $53.74 M(+691.6%) | $77.08 M(+228.4%) |
| Mar 2008 | - | $6.79 M(-14.9%) | $23.47 M(+40.7%) |
| Dec 2007 | $16.68 M(+4396.8%) | $7.98 M(-6.8%) | $16.68 M(+91.7%) |
| Sept 2007 | - | $8.57 M(+6198.5%) | $8.70 M(+6298.5%) |
| June 2007 | - | $136.00 K(-63.3%) | $136.00 K(-67.1%) |
| Dec 2006 | $371.00 K(+562.5%) | - | - |
| Mar 2006 | - | $371.00 K(+2550.0%) | $413.00 K(+637.5%) |
| Dec 2005 | $56.00 K(-95.0%) | $14.00 K(0.0%) | $56.00 K(-82.6%) |
| Sept 2005 | - | $14.00 K(0.0%) | $322.00 K(-45.2%) |
| June 2005 | - | $14.00 K(0.0%) | $588.00 K(-31.1%) |
| Mar 2005 | - | $14.00 K(-95.0%) | $854.00 K(-23.8%) |
| Dec 2004 | $1.12 M(-15.8%) | $280.00 K(0.0%) | $1.12 M(+33.3%) |
| Sept 2004 | - | $280.00 K(0.0%) | $840.00 K(+50.0%) |
| June 2004 | - | $280.00 K(0.0%) | $560.00 K(+100.0%) |
| Mar 2004 | - | $280.00 K | $280.00 K |
| Dec 2003 | $1.33 M(+258.5%) | - | - |
| Dec 2002 | $371.00 K | - | - |
FAQ
- What is Paratek Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual revenue year-on-year change?
- What is Paratek Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly revenue year-on-year change?
- What is Paratek Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM revenue year-on-year change?
What is Paratek Pharmaceuticals annual revenue?
The current annual revenue of PRTK is $150.79 M
What is the all time high annual revenue for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual revenue is $150.79 M
What is Paratek Pharmaceuticals annual revenue year-on-year change?
Over the past year, PRTK annual revenue has changed by +$29.84 M (+24.67%)
What is Paratek Pharmaceuticals quarterly revenue?
The current quarterly revenue of PRTK is $38.06 M
What is the all time high quarterly revenue for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly revenue is $72.63 M
What is Paratek Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, PRTK quarterly revenue has changed by +$10.51 M (+38.13%)
What is Paratek Pharmaceuticals TTM revenue?
The current TTM revenue of PRTK is $167.74 M
What is the all time high TTM revenue for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM revenue is $167.74 M
What is Paratek Pharmaceuticals TTM revenue year-on-year change?
Over the past year, PRTK TTM revenue has changed by +$66.69 M (+66.00%)